State of Wisconsin Investment Board
ITOS

State of Wisconsin Investment Board’s iTeos Therapeutics ITOS Stock Holding History

State of Wisconsin Investment Board’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-48,096
Closed -$480K – 2447
2025
Q2 		$480K Buy
+48,096
New +$387K ﹤0.01% 1887
2024
Q1 		– Sell
-44,804
Closed -$491K – 2328
2023
Q4 		$491K Sell
44,804
-9,099
-17% -$90.2K ﹤0.01% 1758
2023
Q3 		$590K Sell
53,903
-11,131
-17% -$142K ﹤0.01% 1661
2023
Q2 		$861K Buy
65,034
+21,265
+49% +$303K ﹤0.01% 1517
2023
Q1 		$596K Buy
43,769
+25,128
+135% +$450K ﹤0.01% 1785
2022
Q4 		$364K Sell
18,641
-1,206
-6% -$23.6K ﹤0.01% 2023
2022
Q3 		$378K Buy
19,847
+3,468
+21% +$79.9K ﹤0.01% 2109
2022
Q2 		$337K Sell
16,379
-10,521
-39% -$250K ﹤0.01% 2271
2022
Q1 		$866K Hold
26,900
– – ﹤0.01% 1671
2021
Q4 		$1.25M Buy
26,900
+11,900
+79% +$396K ﹤0.01% 1381
2021
Q3 		$405K Hold
15,000
– – ﹤0.01% 1743
2021
Q2 		$385K Hold
15,000
– – ﹤0.01% 1758
2021
Q1 		$513K Hold
15,000
– – ﹤0.01% 1592
2020
Q4 		$507K Buy
+15,000
New +$397K ﹤0.01% 1533

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

State of Wisconsin Investment Board's ITOS Position: Q3 2025 in Review

State of Wisconsin Investment Board sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 48,096 shares — an estimated $480K sold.

State of Wisconsin Investment Board first reported a position in ITOS in Q4 2020 and held it in 14 quarters. The position peaked at $1.25M in Q4 2021. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • State of Wisconsin Investment Board reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 48,096 iTeos Therapeutics shares in Q3 2025, an estimated $480K.
  • State of Wisconsin Investment Board first reported a position in iTeos Therapeutics in Q4 2020 and held it in 14 quarters.
  • State of Wisconsin Investment Board's iTeos Therapeutics position peaked at $1.25M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2025, filed 14 Nov 2025.